Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

145.04
Delayed Data
As of Feb 05
 -4.87 / -3.25%
Today’s Change
130.09
Today|||52-Week Range
181.81
-10.65%
Year-to-Date
AMGN Regular Dividend: AMGN will begin trading ex-dividend on 02/11/16 with a $1.00 dividend payable to shareholders of record as of 02/16/16.

Today’s Trading

Previous close149.91
Today’s open148.93
Day’s range143.69 - 149.39
Volume6,451,924
Average volume (3 months)3,915,340
Market cap$109.4B
Dividend yield2.76%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+7.30%
P/E ratio17.3
Price/Sales6.12
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.54-1.78%
BIIBBiogen-9.41-3.44%
BXLTBaxalta Inc-0.91-2.34%
BAXBaxter International...-0.80-2.09%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateApril 19, 2016
EPS forecast (this quarter)$2.59
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers